Anna Löfdahl - Concepedia

Author

Anna Löfdahl

Lund University

Also Known As

A Lofdahl, A Löfdahl, Anna Lfdahl, Anna Löfdahl, Löfdahl, Anna

Publications

346

Citations

H-Index

Concepts

All Affiliations

Lund University Sahlgrenska University Hospital Skåne University Hospital Karolinska Institutet

About

Anna Löfdahl is an author at Lund University specializing in medicine, lung cancer, and extracellular matrix.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	109
2	Engineering	1	1	59
3	Biomedical Engineering	1	1	59
4	Cell Biology	1	1	59
5	Cellular Physiology	1	1	59

Anna Löfdahl

Publications

232

Citations

H-Index

Page 1

	Year	Citations
Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary Fibrosis Linda Elowsson, Anna Löfdahl, Emma Åhrman, International Journal of Molecular Sciences Tissue EngineeringEngineeringInflammatory Lung DiseaseAdvanced Lung DiseasePathology	2019	59
5‐<scp>HT</scp><sub>2B</sub> receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo Anna Löfdahl, Kristina Rydell‐Törmänen, Catharina Müller, Physiological Reports	2016	30
Effects of 5-Hydroxytryptamine Class 2 Receptor Antagonists on Bronchoconstriction and Pulmonary Remodeling Processes Anna Löfdahl, Christina Wenglén, Kristina Rydell‐Törmänen, American Journal Of Pathology Asthma5-Hydroxytryptamine Class 2Pulmonary CirculationMedicinePhysiology	2018	29
Silver Nanoparticles Alter Cell Viability Ex Vivo and in Vitro and Induce Proinflammatory Effects in Human Lung Fibroblasts Anna Löfdahl, Andreas Jern, Samuel Flyman, Nanomaterials	2020	26
Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis Dimitrios Kalafatis, Anna Löfdahl, Per Näsman, International Journal of Molecular Sciences Inflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunologyPathology	2021	21
Effects of hypoxia on bronchial and alveolar epithelial cells linked to pathogenesis in chronic lung disorders Rebecca Berggren-Nylund, Martin Ryde, Anna Löfdahl, Frontiers in Physiology	2023	20
Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro – a potential pathway affecting proliferation Anna Löfdahl, Kristina Rydell‐Törmänen, Anna‐Karin Larsson‐Callerfelt, Scientific Reports	2018	16
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study Viggo Hamberg, Azita Sohrabian, Elizabeth R. Volkmann, Arthritis Research & Therapy	2023	16
CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts Måns Kadefors, Sara Rolandsson Enes, Emma Åhrman, Scientific Reports	2021	15

Page 1